Heat-shock proteins DnaK and GroEL facilitate export of LacZ hybrid proteins in E. coli

Nature
G J Phillips, T J Silhavy

Abstract

The use of lacZ gene fusions, producing a hybrid protein containing an amino terminus specified by a target gene fused to the functional carboxy terminus of beta-galactosidase, has facilitated the study of protein targeting in various organisms. One of the best characterized fusions in Escherichia coli is phi(lamB-lacZ)42-1(Hyb), which produces a hybrid protein with the signal sequence and 181 N-terminal amino acids of the exported protein LamB, attached to LacZ. In common with other LacZ hybrids, the LamB-LacZ(42-1) protein is poorly exported from E. coli, conferring a Lac+ phenotype. beta-Galactosidase activity decreases markedly when cells producing the LamB-LacZ protein are grown at 42 degrees C or when a heat-shock response is induced at lower temperatures by overproducing heat-shock factor RpoH3, indicating the LacZ hybrids are being efficiently targeted to the cell envelope. We now report that the heat-shock proteins DnaK and GroEL can, in sufficient amounts, decrease beta-galactosidase activity and facilitate the export of lacZ-hybrid proteins.

References

Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·C P Georgopoulos, B Hohn
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·T J SilhavyM Schwartz
Mar 1, 1986·Molecular & General Genetics : MGG·O FayetC Georgopoulos
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J C Bardwell, E A Craig
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S A BensonT J Silhavy
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·K TillyC Georgopoulos

❮ Previous
Next ❯

Citations

Jun 1, 1993·Molecular & General Genetics : MGG·M Chen, V Nagarajan
Sep 1, 1993·Enzyme and Microbial Technology·C E Kalbach, A A Gatenby
Jan 1, 1992·Journal of Biotechnology·A HeitzerG Hamer
Jan 1, 1994·Biotechnology Advances·D D Mosser, B Massie
Oct 1, 1991·Current Opinion in Biotechnology·M BrawnerJ Westpheling
Oct 1, 1993·Current Opinion in Biotechnology·P O Olins, S C Lee
Apr 1, 1991·Trends in Biochemical Sciences·E A Craig, C A Gross
Apr 1, 1996·Current Opinion in Biotechnology·G Georgiou, P Valax
Jan 5, 2000·Microbes and Infection·M G Schmidt, K B Kiser
Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·S L Wang, X Q Liu
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·K LiberekC Georgopoulos
May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S M SimonG F Oster
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J YuanK Cline
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J H Alix, M F Guérin
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K Liberek, C Georgopoulos
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·L Weiner, P Model
Oct 7, 2010·The Journal of Biological Chemistry·David WickströmJan-Willem de Gier
May 1, 1991·Molecular Microbiology·V P KontinenM Sarvas
Jan 15, 1994·European Journal of Biochemistry·J Becker, E A Craig
Jun 21, 1991·Science·J E Bailey
Nov 2, 2004·Journal of Bacteriology·Adam C Fisher, Matthew P DeLisa
Jan 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·E S BochkarevaA S Girshovich
Jan 1, 1993·Critical Reviews in Toxicology·B M Sanders
Jul 22, 1991·FEBS Letters·H WiechR Zimmerman
Mar 11, 1991·FEBS Letters·P M Pechan
Apr 27, 2013·Mutation Research·Anna M GrudniakKrystyna I Wolska
Jan 12, 2010·Life Sciences·Subash C GuptaDebapratim K Chowdhuri
Feb 13, 2007·Biochemical and Biophysical Research Communications·Yaramah M Zalucki, Michael P Jennings

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.